CLINICAL EXPERIENCE WITH SUSTAINED RELEASE CEPHALEXIN (S-6437)

DOI Web Site PubMed

Bibliographic Information

Other Title
  • 経口用持続性Cephalexin (S-6437) の使用経験
  • ケイコウヨウ ジゾクセイ Cephalexin S- 6437 ノ シヨウ ケ

Search this article

Abstract

Oral sustained release cephalexin (S-6437) was administered to 24 pediatric patients. Daily dose used was 18-60mg/kg, which was divided into two doses and given after breakfast and dinner. The following are the results of the study.<BR>Out of 24 patients, 6 showed very good response, 10 good response, 6 fair, 1 poor and 1 unknown, Ratio of effectiveness was 69.6%.<BR>Two patients were reluctant to receive the drug and, therefore, they took other drugs. The other 22 patients, however, were easily given.<BR>No remarkable side effects due to S-6437 were found.<BR>From the above results, it was recognized that S-6437 has good effectiveness and safety, and that it is convenient to give to children because the frequency of the drug administration is only twice a day.

Journal

Details 詳細情報について

Report a problem

Back to top